With the enactment of the America Invents Act (AIA), companies now have a wide array of tools for challenging and neutralizing patents before they become a threat. Each tool has its advantages and disadvantages, but collectively they may allow companies to head
Read More
When I talk to lawyers who do not practice patent law, they often speak of the complexity of patent cases in terms of the scientific or technological issues involved. What many of them fail to understand is that quite apart from the
Read More
The courts continue to wrestle with the difficult question of what types of things can be patented (i.e., what constitutes statutory subject matter). Last week, the Federal Circuit Court of Appeals issued its post-remand opinion in Association for Molecular Pathology, et al.,
Read More
In a recent newsletter, we discussed CLS Bank Int’l, et al. v. Alice Corp. Pty. Ltd. (Case No. 2011-1301)(Fed. Cir. 2012) and the Federal Circuit’s efforts to provide guidance as to the patentability of software in the wake of the Supreme Court’s
Read More
In one of our recent posts, we discussed a technique (“poisoning the well”) that third parties can use to get the examiner who is handling a competitor’s patent application to consider prior art that is not currently of record. Instead of sending
Read More
Many companies build an IP portfolio around particular products, and the portfolio evolves over time as new refinements and improvements to the original concept are developed. This sometimes raises the question of whether various different inventions should be consolidated into a single
Read More
The process of examining U.S. patent application is ex parte and does not involve third parties. The examination is based on the prior art that the applicant submits to the Patent Office and the prior art that the examiner uncovers in his
Read More
We have had the pleasure of working with some inventors who have enjoyed huge success by developing cutting-edge medical devices. This is an area that many people want to break into because it can be very profitable. However, the medical device
Read More
In KSR v. Teleflex, the Supreme Court described numerous reasons for combining or modifying prior art references in an obviousness analysis. The Court also made clear that these reasons need not be explicitly set forth in the prior art references themselves. In
Read More
Once a USPTO examiner issues a “final” rejection against your patent application, your options become limited. They include 1) filing a Notice of Appeal to the Board of Patent Appeals & Interferences, 2) filing a Request for Continued Examination (“RCE”), 3) abandoning
Read More